Natera, Inc. (NTRA), a diagnostics company, Monday announced that it has acquired the non-invasive pre-natal screening and carrier screening business of medical genetics company, Invitae (NVTA).
Natera has made an upfront payment of $10 million and will pay an additional $42.5 million as potential milestone payments to Invitae.
On the other hand, Invitae will transition its non-invasive prenatal screening and carrier screening to Natera's customers.
On Friday, Natera shares closed at $66.63, down 1.38% on the Nasdaq and in pre-market activity, Invitae shares are trading at $0.44, up 3.51% on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.